Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System

被引:19
|
作者
Bkaily, Ghassan [1 ]
Jacques, Danielle [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Immunol & Cell Biol, Sherbrooke, PQ J1H 5N4, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
calcium; calcium homeostasis; calcium overload; hypercalcemia; Cav1; Cav2; Cav3; L-type calcium channel; P/Q-type calcium channel; N-type calcium channel; R-type calcium channel; T-type calcium channel; calcium channel blockers; G protein; GPCR; calcium pumps; sodium; calcium exchanger; endoplasmic reticulum; nucleus; mitochondria; NA+-H+ EXCHANGER; SMOOTH-MUSCLE; PROTEIN-KINASE; SARCOPLASMIC-RETICULUM; NA+/CA2+ EXCHANGER; CA2+ CHANNEL; RYANODINE RECEPTOR; NA+-CA2+ EXCHANGER; CATION CHANNEL; HEART-CELLS;
D O I
10.3390/ijms24108803
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calcium is a highly positively charged ionic species. It regulates all cell types' functions and is an important second messenger that controls and triggers several mechanisms, including membrane stabilization, permeability, contraction, secretion, mitosis, intercellular communications, and in the activation of kinases and gene expression. Therefore, controlling calcium transport and its intracellular homeostasis in physiology leads to the healthy functioning of the biological system. However, abnormal extracellular and intracellular calcium homeostasis leads to cardiovascular, skeletal, immune, secretory diseases, and cancer. Therefore, the pharmacological control of calcium influx directly via calcium channels and exchangers and its outflow via calcium pumps and uptake by the ER/SR are crucial in treating calcium transport remodeling in pathology. Here, we mainly focused on selective calcium transporters and blockers in the cardiovascular system.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Application of calcium channel blockers in the treatment of cardiovascular diseases
    Herman, ZS
    POLISH JOURNAL OF PHARMACOLOGY, 1999, 51 (02): : 201 - 206
  • [2] CALCIUM ENTRY BLOCKERS AND THE CARDIOVASCULAR-SYSTEM - INTRODUCTION - WHY CALCIUM BLOCKERS
    VANHOUTTE, PM
    FEDERATION PROCEEDINGS, 1981, 40 (14) : 2851 - 2851
  • [3] Glucose transporters in cardiovascular system in health and disease
    Luc Bertrand
    Julien Auquier
    Edith Renguet
    Marine Angé
    Julien Cumps
    Sandrine Horman
    Christophe Beauloye
    Pflügers Archiv - European Journal of Physiology, 2020, 472 : 1385 - 1399
  • [4] Glucose transporters in cardiovascular system in health and disease
    Bertrand, Luc
    Auquier, Julien
    Renguet, Edith
    Ange, Marine
    Cumps, Julien
    Horman, Sandrine
    Beauloye, Christophe
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2020, 472 (09): : 1385 - 1399
  • [5] CALCIUM BLOCKERS AND CARDIOVASCULAR PREVENTION
    Bendersky, Mario
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2005, 34 (01): : 55 - 60
  • [6] Ion transporters in cardiovascular diseases
    Bril, A
    BIOFUTUR, 2003, (237) : 28 - +
  • [7] Dysregulation of Calcium Homeostasis: An Important Factor Leading to Ferroptosis in Cardiovascular Diseases
    Zhang, Yifan
    Zheng, Leiyin
    Che, Tongtong
    Meng, Ning
    CELL BIOLOGY INTERNATIONAL, 2025,
  • [8] Cyclophilin A in Cardiovascular Homeostasis and Diseases
    Satoh, Kimio
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 235 (01): : 1 - 15
  • [9] Calcium Channel Blockers in Cardiovascular Pharmacotherapy
    Godfraind, Theophile
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (06) : 501 - 515
  • [10] CALCIUM ENTRY BLOCKERS AND CARDIOVASCULAR FAILURE
    VANHOUTTE, PM
    FEDERATION PROCEEDINGS, 1981, 40 (14) : 2882 - 2887